DMK Pharmaceuticals financials at a glance
| Year | Year | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $6.47M | $13.07M | $15.09M | $22.11M | $2.78M | $2.21M | $4.76M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 25.03% | 43.24% | 35.06% | 28.55% | -127.87% | -211.14% | -30.10% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -188.88% | -261.51% | -132.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-77.70 | $-71.40 | $-83.30 | $-60.49 | $-70.16 | $0.00 | ||||||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
2.71m | 5.04m | 5.48m | 5.82m | 9.91m | 10.55m | 13.43m | 21.58m | 33.39m | 47.29m | 61.63m | 93.66m | 148.89m | 2.14m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $-8.75M | $-10.34M | $-21.16M | $-15.13M | $-32.66M | $-19.89M | $-20.62M | $-37.72M | $-25.91M | $0.00M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $-6.88M | $-10.34M | $-21.28M | $-17.20M | $-36.19M | $-22.76M | $-21.07M | $-38.94M | $-26.59M | $-18.01M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.83 | $-0.78 | $-1.22 | $-0.61 | $-0.93 | $-0.43 | $-0.27 | $-0.27 | $-12.42 | $0.00 | $0.00 |